Alastair has over 30 years of experience in the biopharmaceutical development of pre- and post-approval drugs.
From 2001-2017, Alastair held a variety of senior positions at AstraZeneca, including latterly as Global Head of Delivery for Real World Evidence (RWE). Here, he had responsibility for the delivery of both pre and post approval evidence generation programmes supporting key assets that have gone on to become world class products.
From 2017-2024 he worked at Syneos Health, a world leading Product Development Organization. As a Senior Vice President of Strategic Alliances, he assisted key clients to clinically develop and successfully commercialize assets, particularly through the generation of Real-World Evidence. Now at Sciensus, Alastair successfully helps our biopharma clients gain access to patients and patient data, across Europe. This supports planning and delivery of Integrated Evidence Plans for Regulatory, Payer, Physician and Patient decision making.
